306 related articles for article (PubMed ID: 33831342)
21. Clinical application of 3D display device in ophthalmology: measurement of metamorphopsia.
Kim JW; Kim YT
Acta Ophthalmol; 2016 Feb; 94(1):e54-8. PubMed ID: 26109491
[TBL] [Abstract][Full Text] [Related]
22. Visual Acuity Testing Using a Random Method Visual Acuity Application.
Rhiu S; Lee HJ; Goo YS; Cho K; Kim JH
Telemed J E Health; 2016 Mar; 22(3):232-7. PubMed ID: 26280910
[TBL] [Abstract][Full Text] [Related]
23. Odysight: A Mobile Medical Application Designed for Remote Monitoring-A Prospective Study Comparison with Standard Clinical Eye Tests.
Brucker J; Bhatia V; Sahel JA; Girmens JF; Mohand-Saïd S
Ophthalmol Ther; 2019 Sep; 8(3):461-476. PubMed ID: 31346977
[TBL] [Abstract][Full Text] [Related]
24. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration.
Goldstein M; Loewenstein A; Barak A; Pollack A; Bukelman A; Katz H; Springer A; Schachat AP; Bressler NM; Bressler SB; Cooney MJ; Alster Y; Rafaeli O; Malach R;
Retina; 2005; 25(3):296-303. PubMed ID: 15805906
[TBL] [Abstract][Full Text] [Related]
25. Change in Sub-aspects of Vision-Related Quality of Life after Three Months of Using an App to Categorize Metamorphopsia.
Claessens D; Krüger RV; Grötzinger L
Klin Monbl Augenheilkd; 2023 Sep; 240(9):1091-1097. PubMed ID: 35426105
[TBL] [Abstract][Full Text] [Related]
26. Gaming to improve vision: 21st century self-monitoring for patients with age-related macular degeneration.
Razavi H; Baglin E; Sharangan P; Caruso E; Tindill N; Griffin S; Guymer R
Clin Exp Ophthalmol; 2018 Jul; 46(5):480-484. PubMed ID: 29131493
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional computer-automated threshold Amsler grid test.
Fink W; Sadun AA
J Biomed Opt; 2004; 9(1):149-53. PubMed ID: 14715067
[TBL] [Abstract][Full Text] [Related]
28. Correlation of macular structure and function in a boy with primary foveomacular retinitis and sequence of changes over 5 years.
Badhani A; Padhi TR; Panda GK; Mukherjee S; Das T; Jalali S
Doc Ophthalmol; 2017 Aug; 135(1):43-52. PubMed ID: 28451988
[TBL] [Abstract][Full Text] [Related]
29. Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial.
Ramakrishnan MS; Yu Y; VanderBeek BL
JAMA Ophthalmol; 2020 Mar; 138(3):237-242. PubMed ID: 32027349
[TBL] [Abstract][Full Text] [Related]
30. Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study.
Do DV; Gower EW; Cassard SD; Boyer D; Bressler NM; Bressler SB; Heier JS; Jefferys JL; Singerman LJ; Solomon SD
Ophthalmology; 2012 Apr; 119(4):771-8. PubMed ID: 22297028
[TBL] [Abstract][Full Text] [Related]
31. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Accuracy of Technology-based Eye Care Services: The Technology-based Eye Care Services Compare Trial Part I.
Maa AY; Medert CM; Lu X; Janjua R; Howell AV; Hunt KJ; McCord S; Giangiacomo A; Lynch MG
Ophthalmology; 2020 Jan; 127(1):38-44. PubMed ID: 31522900
[TBL] [Abstract][Full Text] [Related]
33. Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts.
Falkenstein IA; Cochran DE; Azen SP; Dustin L; Tammewar AM; Kozak I; Freeman WR
Ophthalmology; 2008 Feb; 115(2):319-23. PubMed ID: 17706288
[TBL] [Abstract][Full Text] [Related]
34. Qualifying to Use a Home Monitoring Device for Detection of Neovascular Age-Related Macular Degeneration.
Thomas M; Wolfson Y; Zayit-Soudry S; Bressler SB; Bressler NM
JAMA Ophthalmol; 2015 Dec; 133(12):1425-30. PubMed ID: 26468999
[TBL] [Abstract][Full Text] [Related]
35. Association of Visual Function Measures with Drusen Volume in Early Stages of Age-Related Macular Degeneration.
Pondorfer SG; Wintergerst MWM; Gorgi Zadeh S; Schultz T; Heinemann M; Holz FG; Finger RP
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):55. PubMed ID: 32232348
[TBL] [Abstract][Full Text] [Related]
36. Preferential hyperacuity perimeter as a functional tool for monitoring exudative age-related macular degeneration in patients treated by intravitreal ranibizumab.
Querques G; Querques L; Rafaeli O; Canoui-Poitrine F; Bandello F; Souied EH
Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):7012-8. PubMed ID: 21885622
[TBL] [Abstract][Full Text] [Related]
37. Novel quantitative assessment of metamorphopsia in maculopathy.
Wiecek E; Lashkari K; Dakin SC; Bex P
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):494-504. PubMed ID: 25406293
[TBL] [Abstract][Full Text] [Related]
38. Performance of an iPad Application to Detect Moderate and Advanced Visual Field Loss in Nepal.
Johnson CA; Thapa S; George Kong YX; Robin AL
Am J Ophthalmol; 2017 Oct; 182():147-154. PubMed ID: 28844641
[TBL] [Abstract][Full Text] [Related]
39. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
[TBL] [Abstract][Full Text] [Related]
40. Monitoring of photodynamic therapy results in age-related macular degeneration by means of preferential hyperacuity perimeter.
Wylegala EA; Pilat J; Teper SJ; Wroblewska-Czajka E; Bartusek M
Eur J Ophthalmol; 2007; 17(5):768-75. PubMed ID: 17932853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
